The role of histone deacetylase 9 in the imbalance of Th17/Treg in bronchial asthma

X. Hou, G. Shi, X. Ai, Y. Ni (Shanghai, China)

Source: Annual Congress 2012 - Mechanisms of asthma
Session: Mechanisms of asthma
Session type: Oral Presentation
Number: 358
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
X. Hou, G. Shi, X. Ai, Y. Ni (Shanghai, China). The role of histone deacetylase 9 in the imbalance of Th17/Treg in bronchial asthma. Eur Respir J 2012; 40: Suppl. 56, 358

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Decreased histone deacetylase activity in COPD
Source: Annual Congress 2008 - Epigenetic modifications in lung disease
Year: 2008


Histone deacetylase activity and gene expression in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 316s
Year: 2001

Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer
Source: ERS Lung Science Conference 2017
Year: 2017

Histone deacetylase activity is reduced in COPD. Modulation by theophylline
Source: Eur Respir J 2003; 22: Suppl. 45, 4s
Year: 2003

microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015


Low-dose theophylline improves lung inflammatory profile during COPD exacerbations by increasing histone deacetylase activity
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008


Histone deacetylases reduction causes defect of Nrf2 response, leading to a reduction of anti-oxidant capacity in COPD
Source: Annual Congress 2010 - Pathology and immunology of COPD
Year: 2010

Histone acetylation and deacetylation: importance in inflammatory lung diseases
Source: Eur Respir J 2005; 25: 552-563
Year: 2005



LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Steroids and histone deacetylase in ventilation-induced gene transcription
Source: Eur Respir J 2007; 30: 865-877
Year: 2007



The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS)
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Citrullinated histone H3 is increased in blood of asthma subjects
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019

IFNγ influences bronchial epithelial anti-viral immune responses via inducible epigenetic control of histone methylation of the RIG-I promoter
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015


Histone deacetylases (HDACs) and lung disease
Source: Annual Congress 2011 - Why is epigenetics important for lung disease?
Year: 2011


Expression of histone deacetylases (HDAC3) and phosporylated-cAMP response element-binding (P-CREB) in bronchial biopsies of asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 470s
Year: 2004

A role for histone acetylation/deacetylation in TNFα production from macrophages exposed to PM10
Source: Eur Respir J 2001; 18: Suppl. 33, 407s
Year: 2001

Histone deacetylation and acetylation status in memory T lymphocytes relates to allergen-induced eosinophil inflammation in lung
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Implication of the histone methyltransferase EZH2 in pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018



Global histone H3 lysine 4 (H3K4) dimethylation is an important prognostic factor in lung cancer
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012